Scientific Concept of the National Cohort (status ... - Nationale Kohorte

More documents

Recommendations

Info

C.3 References 526. Mack, F., et al., Study of Health in Pomerania (SHIP): Relationship among socioeconomic and general health factors and dental status among elderly adults in Pomerania. Quintessence international, 2003. 34(10): p. 772-778. 527. Mundt, T., et al., Socioeconomic indicators and prosthetic replacement of missing teeth in a working age population–Results of the Study of Health in Pomerania (SHIP). Community Dentistry and Oral Epidemiology, 2009. 37(2): p. 104-115. 528. Mack, F., et al., The impact of tooth loss on general health related to quality of life among elderly Pomeranians: results from the study of health in Pomerania (SHIP- O). The International journal of prosthodontics, 2005. 18(5): p. 414. 529. Sanders, A.E., et al., Impact of oral disease on quality of life in the US and Australian populations. Community Dentistry and Oral Epidemiology, 2009. 37(2): p. 171-181. 530. John, M.T., W. Micheelis, and R. Biffar, Normwerte mundgesundheitsbezogener Lebensqualitat fur Kurzversionen des Oral Health Impact Profile. SCHWEIZER MONATSSCHRIFT FUR ZAHNMEDIZIN, 2004. 114(8): p. 784-791. 531. John, M.T., et al., German short forms of the oral health impact profile. Community Dentistry and Oral Epidemiology, 2006. 34(4): p. 277-288. 532. Lagerros, Y.T. and P. Lagiou, Assessment of physical activity and energy expenditure in epidemiological research of chronic diseases. European journal of epidemiology, 2007. 22(6): p. 353-362. 533. Ferrari, P., C. Friedenreich, and C.E. Matthews, The role of measurement error in estimating levels of physical activity. American journal of Epidemiology, 2007. 166(7): p. 832. 534. Bingham, S., et al., Associations between dietary methods and biomarkers, and between fruits and vegetables and risk of ischaemic heart disease, in the EPIC Norfolk Cohort Study. International journal of epidemiology, 2008. 37(5): p. 978. 535. Bundesministeriums für Umwelt, N.u.R., Umweltradioaktivität und Strahlenbelastung 2006. Unterrichtung durch die Bundesregierung Drucksache.16/6835.16. Wahlperiode. 2007, Bundesministeriums für Umwelt, Naturschutz und Reaktorsicherheit: Berlin. p. 1-75. 536. European Foundation for the Improvement of Living and Working Conditions, Fourth European Working Conditions Survey. 2007, Office for Official Publications of the European Communities: Luxembourg. 537. Harrington, J.M., Health effects of shift work and extended hours of work. Occupational and environmental medicine, 2001. 58(1): p. 68. 538. International Agency for Research on Cancer, Painting, Firefighting, and Shiftwork., in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2010, IARC: Lyon. 539. European Agency for Safety and Health at Work, E., Noises in figures. 2005, Office for Official Publications of the European Communities: Luxembourg. 540. Jonas, D.E., et al., Patient time requirements for screening colonoscopy. The American journal of gastroenterology, 2007. 102(11): p. 2401-2410. 541. Russell, L.B., Completing costs: patients' time. Medical care, 2009. 47(7_Supplement_1): p. S89. 542. Russell, L.B., D.C. Suh, and M.A. Safford, Time requirements for diabetes selfmanagement: too much for many. J Fam Pract, 2005. 54(1): p. 52-56. 318
319 References 543. Holle, R., et al., KORA--a research platform for population based health research. Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)), 2005. 67: p. S19. 544. Haynes, R.B., et al., Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews, 2008. 2. 545. Shi, L., et al., Correlation between adherence rates measured by MEMS and selfreported questionnaires: a meta-analysis. Health and Quality of Life Outcomes, 2010. 8: p. 99. 546. Gehi, A.K., et al., Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Archives of Internal Medicine, 2007. 167(16): p. 1798. 547. Morisky, D.E., et al., Five-year blood pressure control and mortality following health education for hypertensive patients. American Journal of Public Health, 1983. 73(2): p. 153. 548. Lawes, C.M.M., S.V. Hoorn, and A. Rodgers, Global burden of blood-pressurerelated disease, 2001. The Lancet, 2008. 371(9623): p. 1513-1518. 549. Lewington, S., et al., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 2002. 360(9349): p. 1903. 550. Duron, E. and O. Hanon, Hypertension, cognitive decline and dementia. Archives of Cardiovascular Diseases, 2008. 101(3): p. 181-189. 551. Kennelly, S.P., B.A. Lawlor, and R.A. Kenny, Blood pressure and the risk for dementia--A double edged sword. Ageing research reviews, 2009. 8(2): p. 61-70. 552. Moretti, R., et al., Risk factors for vascular dementia: Hypotension as a key point. Vascular Health and Risk Management, 2008. 4(2): p. 395. 553. Paglieri, C., et al., Hypertension and cognitive function. Clinical and Experimental Hypertension, 2008. 30(8): p. 701-710. 554. Qiu, C., B. Winblad, and L. Fratiglioni, The age-dependent relation of blood pressure to cognitive function and dementia. The Lancet Neurology, 2005. 4(8): p. 487-499. 555. Davy, K.P. and J.E. Hall, Obesity and hypertension: two epidemics or one? American Journal of Physiology- Regulatory, Integrative and Comparative Physiology, 2004. 286(5): p. R803. 556. Francischetti, E.A. and V.A. Genelhu, Obesity–hypertension: an ongoing pandemic. International journal of clinical practice, 2007. 61(2): p. 269-280. 557. Mathieu, P., et al., Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension, 2009. 53(4): p. 577. 558. Meisinger, C., A. Döring, and M. Heier, Blood pressure and risk of type 2 diabetes mellitus in men and women from the general population: the Monitoring Trends and Determinants on Cardiovascular Diseases/Cooperative Health Research in the Region of Augsburg Cohort Study. Journal of hypertension, 2008. 26(9): p. 1809. 559. Palatini, P., Elevated heart rate as a predictor of increased cardiovascular morbidity. Journal of hypertension. Supplement: official journal of the International Society of Hypertension, 1999. 17(3): p. S3. C.3
Page 1:
The National Cohort A prospective e
Page 4 and 5:
Applicants Applicants Applicants Cl
Page 6 and 7:
Applicants IV
Page 8 and 9:
Executive Summary 2. The National C
Page 10 and 11:
Executive Summary 3. Scientific aim
Page 12 and 13:
Executive Summary essary to address
Page 14 and 15:
Executive Summary 7. Examples for s
Page 16 and 17:
Contents A.2.4 major areas of expos
Page 18 and 19:
Contents A.3.8.2 Social security da
Page 20 and 21:
Contents A.6.4.2 Minimally detectab
Page 22 and 23:
Abbreviations C.2 mEThOdS fOr STATI
Page 24 and 25:
Abbreviations DXA Dual-energy x-ray
Page 26 and 27:
Abbreviations CHS Cardiovascular He
Page 28 and 29:
A.1 A.1 Introduction and overview a
Page 30 and 31:
A.1 A.1 Introduction and overview s
Page 32 and 33:
A.1 A.1 Introduction and overview T
Page 34 and 35:
A.1 A.1 Introduction and overview m
Page 36 and 37:
A.1 A.1 Introduction and overview
Page 38 and 39:
A.1 A.1 Introduction and overview s
Page 40 and 41:
A.1 A.1 Introduction and overview
Page 42 and 43:
A.1 A.1 Introduction and overview P
Page 44 and 45:
A.1 A.1 Introduction and overview t
Page 46 and 47:
A.1 A.1 Introduction and overview A
Page 48 and 49:
A.2 A.2. Scientific background and
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
A.3 A.3 Study design ment instrumen
Page 84 and 85:
A.3 A.3 Study design Table 3.2: Des
Page 86 and 87:
A.3 A.3 Study design Table 3.3: Dis
Page 88 and 89:
A.3 A.3 Study design the participan
Page 90 and 91:
A.3 A.3 Study design with a prepare
Page 92 and 93:
A.3 A.3 Study design rural areas, t
Page 94 and 95:
A.3 A.3 Study design A.3.2 Baseline
Page 96 and 97:
A.3 A.3 Study design Modules 70 Int
Page 98 and 99:
A.3 A.3 Study design ovarian carcin
Page 100 and 101:
A.3 A.3 Study design Table 3.5: Spe
Page 102 and 103:
A.3 A.3 Study design depression and
Page 104 and 105:
A.3 A.3 Study design to the extent
Page 106 and 107:
A.3 A.3 Study design ers to vaccina
Page 108 and 109:
A.3 A.3 Study design certain foods)
Page 110 and 111:
A.3 A.3 Study design A short instru
Page 112 and 113:
A.3 A.3 Study design ticipants and
Page 114 and 115:
A.3 A.3 Study design a resting time
Page 116 and 117:
A.3 A.3 Study design index, convent
Page 118 and 119:
A.3 A.3 Study design Although the i
Page 120 and 121:
A.3 A.3 Study design air and then t
Page 122 and 123:
A.3 A.3 Study design hemorrhages (0
Page 124 and 125:
A.3 A.3 Study design genetics of BM
Page 126 and 127:
A.3 A.3 Study design hand grip stre
Page 128 and 129:
A.3 A.3 Study design Project title
Page 130 and 131:
A.3 A.3 Study design diseases in va
Page 132 and 133:
A.3 A.3 Study design associations,
Page 134 and 135:
A.3 A.3 Study design Informed Conse
Page 136 and 137:
A.3 A.3 Study design 6. Since being
Page 138 and 139:
A.3 A.3 Study design the possible d
Page 140 and 141:
A.3 A.3 Study design A.3.5 Collecti
Page 142 and 143:
A.3 A.3 Study design Blood In addit
Page 144 and 145:
A.3 A.3 Study design the anterior n
Page 146 and 147:
A.3 A.3 Study design study. For exa
Page 148 and 149:
A.3 A.3 Study design large-size sto
Page 150 and 151:
A.3 A.3 Study design routinely prep
Page 152 and 153:
A.3 A.3 Study design Subjects who m
Page 154 and 155:
A.3 A.3 Study design A.3.6.3 reliab
Page 156 and 157:
A.3 A.3 Study design In addition, a
Page 158 and 159:
A.3 A.3 Study design Disease Questi
Page 160 and 161:
A.3 A.3 Study design Data routinely
Page 162 and 163:
A.3 A.3 Study design tial misclassi
Page 164 and 165:
A.3 A.3 Study design � The KORA c
Page 166 and 167:
A.3 A.3 Study design Table 3.16: Co
Page 168 and 169:
A.3 A.3 Study design Table 3.17: Co
Page 170 and 171:
A.4 A.4 Integrated Data Management
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
A.5 A.5 Methods for quality assuran
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
A.6 A.6 Planned statistical analyse
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
A.6 A.6 Table Planned 6.4: Expected
Page 206 and 207:
Page 208 and 209:
A.6 Planned statistical analyses an
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
A.7 A.7 Ethical aspects logical/gen
Page 220 and 221:
A.7 A.7 Ethical aspects The more ex
Page 222 and 223:
A.7 A.7 Ethical aspects pants, trav
Page 224 and 225:
A.7 A.7 Ethical aspects Data handli
Page 226 and 227:
A.7 Table 7.2 Availability of ident
Page 228 and 229:
A.7 A.7 Ethical aspects Should bios
Page 230 and 231:
A.7 A.7 Ethical aspects ing finding
Page 232 and 233:
A.7 A.7 Ethical aspects 206
Page 234 and 235:
C.1 C.1 Annex: Description of the s
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
C.1 C.1 Table Annex: 1: Cluster Des
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277: C.1 C.1 Annex: Description of the s
Page 282 and 283: C.2 C.2 Annex: Methods for Statisti
Page 286 and 287: C.2 Table S6.5: Sample size needed
Page 296 and 297: C.3 References 17. Keil, U., et al.
Page 298 and 299: C.3 References 50. Benjamin, E.J.,
Page 300 and 301: C.3 References 85. Calle, E.E. and
Page 302 and 303: C.3 References 121. Walter, R., D.J
Page 304 and 305: C.3 References 155. Ross, R., Ather
Page 306 and 307: C.3 References 189. Ghiotto, F., et
Page 308 and 309: C.3 References 225. Schmidt, C.O.,
Page 310 and 311: C.3 References 260. Eussen, S., et
Page 312 and 313: C.3 References 294. McCrae, R.R. an
Page 314 and 315: C.3 References 327. Lynch, J.W., G.
Page 316 and 317: C.3 References 360. Mair, C., A.V.
Page 318 and 319: C.3 References 395. Lesourd, B., Nu
Page 320 and 321: C.3 References 431. Statistisches B
Page 322 and 323: C.3 References 462. Bundeszentrale
Page 324 and 325: C.3 References 494. Rammstedt, B. a
Page 328 and 329: C.3 References 560. Palatini, P., A
Page 330 and 331: C.3 References 590. Greenland, P.,
Page 332 and 333: C.3 References 623. Olin, A.C., et
Page 334 and 335: C.3 References 658. Pate, R.R., J.R
Page 336 and 337: C.3 References 691. Zenge, M.O., et
Page 338 and 339: C.3 References 727. Ryu, O.H., et a
Page 340 and 341: C.3 References 757. BSI-Standard 10
Page 342 and 343: C.3 References 790. Davis, C.E., et
Page 344: C.3 References 822. Hegenscheid, K.
show all

Scientific Concept of the National Cohort (status ... - Nationale Kohorte

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?